A single-center randomized double-blind placebo-controlled trial "Treatment of Systemic Sclerosis with Rituximab: evaluation of the effectiveness of B-cell depletion therapy"
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2015 Interim results (n=6, after one treatment course) published in the Clinical and Experimental Rheumatology.
- 24 Aug 2015 New trial record